Compared to insulin, metformin did not increase the maternal, fetal or neonatal risks of
adverse events, and the delivery modes were unaffected. Glycemic control evaluated by …

Metabolic acidosis may occasionally develop in the course of treatment with drugs used in
everyday clinical practice, as well as with the exposure to certain chemicals. Drug-induced …

Clinicians are faced with an expansive array of treatment choices when caring for patients
with type 2 diabetes. Because patient compliance may be affected when media …

2SC [S-(2-succino)-cysteine] is a chemical modification formed by a Michael addition
reaction of fumarate with cysteine residues in proteins. Formation of 2SC, termed …

Background: Metformin reduces maternal and neonatal weight gain in gestational diabetes
mellitus; however, this effect is poorly investigated in non-diabetic women. Objective: We …

An ever-increasing number of women with Type 2 diabetes mellitus (DM) are going through
pregnancy and, with the current epidemic of obesity, more women are being diagnosed with …

Pregnancy is a potentially glucose intolerant condition. Insulin sensitivity decreases as the
pregnancy advances. At the later stage of pregnancy, some women develop Gestational …

Publisher Summary This chapter presents the studies of the effects of insulin, other
hypoglycemic drugs, and glucagon. It reviews a study in which 97 patients, mean age 53 …

Objetivo: Avaliar o controle glicêmico em pacientes que utilizaram metformina ou insulina
para tratamento do diabetes gestacional, identificando fatores preditores da necessidade de …

A 28-year-old woman, who was 22 weeks pregnant, developed lactic acidosis after
consuming an overdose of metformin in a suicide attempt. The woman had been prescribed …